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USE OF FLUORESCENT MICROSPHERES TO MEASURE CORONARY 




Riddhi Harsh Shah 
Heart attacks result from reduced or blocked blood flow through major coronary arteries, 
resulting in permanent damage to heart muscle.  Coronary blood flow (CBF) is thus 
important to measure in experimental animal models of heart disease. A standard method 
to measure CBF uses tracer microspheres (Ø = 15 µm) injected into the left ventricle that 
flow through coronary arteries but cannot pass through capillaries and so become trapped 
in heart muscle. Previously, radioactive or colored microspheres have quantified the 
number of tracers trapped in the muscle.  Fluorescent microspheres offer a more recent 
and more sensitive measurement mode. However, fluorescent microspheres have not 
often been used to measure CBF in small animals (rats, mice) that are now the most 
common animal models used in heart research. This thesis aimed to develop the 
techniques for use of fluorescent microspheres to measure CBF in rat animal models used 
by the cell biology laboratories at UMDNJ-Newark. Two non-overlapping fluorescent 
wavelengths were chosen (yellow-green; red). Using a spectrophotometer, fluorescence 
intensity was calibrated for known numbers of microspheres (set via controlled dilution).  
CBF in two rats was measured at rest and during maximal vasodilation (adenosine) using 
procedures for colored microspheres. After euthanasia, hearts were removed, and blood 
samples and left ventricular tissue were processed using a sedimentation method for full 
recovery of fluorescent microspheres, which were scanned through the spectrophotometer 
 
 
to count fluorescence intensity. Using the predetermined calibration curve, the number of 
microspheres in each sample was determined; from this CBF was calculated. CBF 
averaged 5.9 ml/min/g at rest, which was within the normal range for rats quoted in 
recent literature.  With maximal vasodilation, CBF increased to an average of 12.9 
ml/min/g, which indicated a coronary flow reserve that was 2.2 times the resting level.  
The same value for coronary flow velocity reserve (2.2) was measured in 6 rats using 
Doppler echocardiography. The consistency of these results suggests that the procedures 
developed for fluorescent microspheres lead to repeatable and reliable measurement of 
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1.1 Heart Attack and Coronary Blood Flow 
Heart disease and related conditions affect 12 million Americans and cost $274 billion a 
year [5]. It is the leading cause of death in United States [5]. Unfortunately, many people 
do not realize any potential problems with their heart until they have a heart attack. The 
treatments are generally expensive. The patient has to undergo coronary bypass or 
coronary angioplasty surgery. Today’s lifestyle, eating habits and drinking habits are the 
major cause of heart attacks and stroke [5].  A heart attack occurs when blood vessels that 
supply blood to the heart are blocked, preventing enough oxygen from getting to the 
heart, resulting in death or permanent damage of heart muscle.  
In atherosclerosis, plaque builds up in the walls of coronary arteries. This plaque 
is made up of cholesterol and other cells. A heart attack can occur as a result of the 
following: 
1) The slow buildup of plaque may almost block one of the coronary arteries. A heart 
attack may occur if not enough oxygen-containing blood can flow through this blockage. 
This is more likely to happen during exercise. 
 
2) The plaque itself develops cracks (fissures) or tears. Blood platelets stick to these 
tears and form a blood clot (thrombus). A heart attack can occur if this blood clot 
completely blocks the passage of oxygen-rich blood to the heart. This is the most 
common cause of heart attack. 
 
3) Sudden, significant emotional or physical stress, including an illness, can trigger a 
heart attack, too. 
 
Slow build up of plaque and blockage of coronary arteries is the cause of heart 
attacks. Researchers say that there are two types of plaque: soft plaque, also known as 
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vulnerable plaque, and hard plaque, also known as healed plaque. Soft plaque poses more 
risk to cause a heart attack. Soft plaque produces a small bump beneath the inner lining of 
an artery, the endothelium. If the plaque cracks open or is torn up, it punctures a hole in 
endothelium and thus exposes the contents of plaque to the cells in the blood stream. A 
blood clot then develops at the site of this “injury” as part of what in other circumstances 
would be a healing process. This clot (along with a possible spasm of the affected artery) 
is what most commonly causes obstruction of blood flow, resulting in a heart attack. The 
amount of damage to the heart muscle depends on the size of the area supplied by the 
blocked artery and the time between injury and treatment [18]. 
The coronary arteries carry blood to the heart muscle. Because the heart muscle is 
continuously working (as opposed to other muscles of the body, which are often at rest), 
it has a very high requirement for oxygenated blood. The coronary arteries are vitally 
important for supplying that blood, and allowing the heart to work normally. Because a 
blockage in any of the coronary arteries produces a heart attack or myocardial infarction, 
special care must be taken to monitor coronary arteries and measure coronary blood flow. 
 
1.2 Significance of Coronary Blood Flow 
Coronary arteries are the major arteries that carry oxygenated blood to the heart muscle. 
Two major coronary arteries arise from the aorta- the right coronary artery (RCA) and the 
left main coronary artery (LM). The left main artery quickly branches into two large 
arteries – the left anterior descending artery (LAD) and the circumflex artery. All of these 
coronary arteries lie on the surface of the heart and distribute oxygenated blood to 
different regions of the heart muscle. In case of normal, non-diseased vessels, they have 
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low vascular resistance relative to their more distal and smaller branches that comprise 
the microvascular network [17]. 
 
 
                             





The important features of coronary blood flow:  
 
1) Flow is tightly coupled to oxygen demand. In non-diseased coronary vessels, 
whenever cardiac activity and oxygen consumption increases, there is an increase in 
coronary blood flow that is nearly proportional to the increase in oxygen consumption. 
 
2) Good autoregulation between 60 and 200 mmHg perfusion pressure helps to maintain 
normal coronary blood flow whenever coronary perfusion pressure changes due to 
changes in aortic pressure. 
 
3) Adenosine serves as a metabolic coupler between oxygen consumption and coronary 
blood flow.  
 
4) In the presence of coronary artery disease, coronary blood flow may be reduced. This 
will increase oxygen extraction from the coronary blood and decrease the venous oxygen 
content [7]. 
 
Since oxygenated blood supplied by coronary arteries is an essential factor for 
heart muscle to function normally, it is of prime importance to check for the ability of 
coronary arteries to deliver the required blood flow.  
 
1.3 Use of Laboratory Animals in Biomedical Research 
An animal model represents some, most, or all aspects of a normal or abnormal condition 
in another animal or human being. Abnormal model conditions may be inherited, 
spontaneous, or experimentally-induced. Because of a large number of people suffering 
from heart disease, cerebral strokes, and many other such diseases, tests are being 
performed on animals. Also, death rates are declining because of advances in diagnosis, 
treatment and prevention made through animal research. Between 17 million and 22 
million animals have been estimated annually to be used in biomedical and behavioral 
research, education and testing. About 85% of these are rats and mice, and less than 2% 
are cats, dogs and non-human primates. In the past, most cardiovascular research was 
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performed using canine animal models.  For example, the use of dogs as animal models 
made open-heart surgery through the use of a heart lung machine possible today in 
human beings. Surgery to replace heart valves and large arteries has also been made 
possible only after experimenting on dogs. Although the use of dogs has proved quite 
effective in cardiovascular research, in the last two decades, the use of mice and rats has 
increased to a greater extent, so that now they are the most common animal models [30].  
The commercial availability of rats and mice, plus their small size, high 
reproductive rate, and minimal costs of purchase and maintenance, have made them the 
most studied and perhaps best understood laboratory animal species. In addition, they are 
understood and characterized anatomically, physiologically and genetically. Several 
stocks of rats and mice have withstood the process of inbreeding, allowing the 
commercial production of a large variety of inbred strains and providing the researcher 
with thousands of genetically similar individuals. A large number of mutant strains and 
stocks, with naturally occurring anatomical, physiological, or biochemical diseases, have 
been developed as animal models for similar conditions in humans and other animals. 
They are amenable to germ-free and pathogen-free production techniques, thereby greatly 
reducing attendant, unwanted disease as a variable. Large databases on rodents are 
available as a result of years of selective breeding designed to meet specific research 
requirements for models of human disease [11].  
Mice are used for a broad range of research. Their relatively short life span makes 
them useful in aging research. Mice are the primary mammal used in genetics research 
because of their high reproductive potential and short generation time. They are also used 
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widely in drug testing and cardiovascular research because they respond favorably and 
are economical to use in large numbers [12].  
Transgenic studies in mice have introduced new and valuable strains and 
mutations to biomedical research. Transgenics are produced when foreign DNA is 
integrated into animal cells by experimental means. Such foreign DNA can mimic the 
changes in DNA that cause inherited disease in humans.  In addition, changes in DNA 
produce altered proteins whose function differs from normal, which offers basic scientists 
a method to study the function of these proteins. Mice are ideal for transgenic use due to 
their pronuclei, which are suitable for manipulation [12]. 
 
1.4 Techniques Used Previously to Determine Blood Flow in Rats and Mice 
Radioactive microspheres had originally become the gold standard for measuring 
regional organ perfusion since the technique was introduced in 1967, by Rudolph and 
Heymann for examining regional blood flow in sheep fetuses in utero [35]. This 
technique became an essential tool in cardiovascular research by enabling measurements 
of regional blood flow in any organ. Regional blood flow is proportional to the number of 
microspheres trapped in that region of tissue following injection of the microspheres 
upstream – usually in the left ventricular chamber [35]. Methods for quantifying the 
number of microspheres per sample depends on the label used to track the microspheres, 
the most common being the measurement of nuclear isotope decay from radiolabeled 
microspheres. However the use of radiolabeled microspheres was becoming restricted 
because of the health risks for both the user and the animal in chronic studies, requiring 
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special precautions during the experiments and subsequently during disposal of the 
animals and tissue samples.  
A number of non-radioactive techniques have been proposed, including the use of 
colored microspheres [8][16][23][38] and X-ray fluorescent microspheres [26-27]. But 
they too were not compatible in many different aspects. Colored microspheres 
underestimated regional blood flow since they had limited resolution due to significant 
spectral overlap among different colors, while data variance was high as a result of low 
signal intensity [8][19][27]. The measurement system used for X-ray fluorescent 
microspheres was expensive and available rarely and not in common use [32].  
Consequently, techniques using optically fluorescent microspheres were 
developed to measure regional organ blood flow.  These techniques have been validated 
against traditional radioactive methods, and they provide estimation of regional blood 
flow for about half the cost of radiolabeled microspheres [31-32][38]. Optically 
fluorescent methodologies are currently being used world-wide in cardiovascular 
research.  
 
1.5 Use of Fluorescent Microspheres to Determine Coronary Blood Flow in Animals 
Microsphere methods provide information on regional perfusion between and within 
organs that is more detailed than that available from blood-flow probes, which can only 
be placed around one or two large arteries. Recently, fluorescent microspheres have 
become more commonly used in experiments as they offer numerous advantages as 
compared to radioactive and colored microspheres: 
a) Fluorescent microspheres are cost effective as compared to radioactive microspheres 
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b) Fluorescent microspheres eliminate the hazard and disposal problems caused as in use 
of radioactive microspheres 
c) Blood flow measurements in kidney, lung, pancreas, adrenal glands and teeth are 
easily feasible using fluorescent microspheres 
d) Fluorescent microspheres offer a shelf life of at least one year, so they can be retained 
in the tissue organ which is not possible in case of radioactive microspheres that have 
short lives and their retention is harmful to the tissue organ. 
e) Lastly, fluorescent microspheres offer higher sensitivity, superior color separation 
and greater ease of measurement as compared to colored and radioactive microspheres 
[2][22].  
Fluorescent microspheres have been used for the determination of blood flow in 
lung, kidney and myocardium of dog [1][13]. They have been used for the determination 
of blood flow in myocardium, brain, kidney and skeletal muscle of pig [13][19][25] and 
myocardium of rabbit [2][6]. In addition to absolute blood flow, fluorescent microspheres 
have been used for determination of relative blood flow in different tissues such as liver, 
brain, spleen of dog [38] and regional adrenal gland blood flow in fetal sheep [4]. 
Fluorescent microspheres have even been used to estimate the cardiac output in chick 
embryos [29]. Recently, fluorescent microspheres have been used for determination of 
regional and systemic hemodynamics in rats. Given the validation of fluorescent 
microspheres in rats, fluorescent microspheres have even been attempted for assessment 
of regional and systemic hemodynamics in genetically modified mice [34]. 
Fluorescent microspheres have been used for a wide range of applications 
including blood flow determination, tracing, in vivo imaging, calibration of images and 
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flow cytometry. As the fluorescent dye is incorporated throughout the bead and not just 
on the surface, they are relatively immune to photobleaching and other environmental 
factors. Fluorescent microspheres are available in many different colors: Red, Orange, 
Crimson, Blue, Yellow-green, Green, Blue-green, Scarlet. Each color exhibits a unique 
pair of optical excitation and emission wavelengths. This allows researchers to study the 
effects of multiple physiological variables in the course of a single experiment. The exact 
excitation and emission spectra depend on the solvent used to extract the fluorescent 
dyes. The principal advantage of fluorescence over radioactivity and absorption 
spectroscopy is the ability to separate compounds on the basis of either their excitation or 
emission spectra, as opposed to a single spectrum, as in colored microspheres. 
Fluorescent microspheres are now an emerging technique used in rodents for the 
measurement of regional tissue blood flow. In a few labs, they have been tested on 
myocardial infarction models and pressure overload hypertrophy models in rodents. 15-
micron diameter fluorescent microspheres have also been used to measure cerebral blood 
flow in rats [9]. Measurement of bone blood supply in mice has been recently determined 
by using fluorescent microspheres [36].  However, fluorescent microspheres have not yet 
been used in rodent animal models by the cardiovascular research laboratories at the New 
Jersey Medical School, a division of the University of Medicine and Dentistry of New 
Jersey (UMDNJ).  The work in this thesis lays the groundwork that will enable the use of 
fluorescent microspheres to determine coronary blood flow in rodent animal models in 






1.6 Calculation of Myocardial Blood Flow by use of Fluorescent 
Microspheres 
 
Fluorescent microspheres can be used for the measurement of regional blood flow 
without any concern of spillover of emitted fluorescence. Fluorescent microspheres are 
chemically stable and exhibit no dye leaching in aqueous environments, including strong 
acid and base solutions. The high fluorescent dye content of each individual microsphere 
allows rapid identification and accurate quantification in a liquid suspension containing 
varying levels of background cellular debris [26]. 
To measure myocardial blood flow, microspheres are injected into the left 
ventricle of an experimental animal. The microspheres mix uniformly with the arterial 
blood and flow with it. Some microspheres flow into the blood going through the 
ascending aorta and on to all other parts of the body, and some microspheres are 
distributed into the blood flowing through the coronary arteries.  In the heart tissue fed by 
the coronary arteries – as well as in all other body tissues – the microspheres become 
trapped in the microvasculature because their diameter is too large to allow them to pass 
through capillaries.  
To be able to relate the amount of blood flow in a specific tissue to the number of 
microspheres trapped in that tissue, a reference sample of blood flow must be obtained at 
the same time that the microspheres are injected and flowing throughout the entire 
systemic arterial circulation.  This reference blood flow is usually obtained via a catheter 
placed through the femoral artery into the abdominal aorta of the animal. The magnitude 
of the reference blood flow is controlled and accurately determined by using a high-




After mixing well with the blood in the left ventricle, the concentration of the 
injected microspheres is the same in all the arterial blood flowing to all tissues in the 
body.  Thus, the number of microspheres trapped in a particular tissue will be 
proportional to the magnitude of the blood flow going to that tissue.  This proportion also 
holds for the blood flow going into the reference blood-flow sample.  Consequently, the 
following equation is valid:  
Blood flow to heart       =       Number of microspheres in heart sample 
               Reference blood flow             Number of microspheres in blood sample       (1.1) 
Following extraction and quantification of the number of fluorescent 
microspheres from both the heart tissue and the reference blood sample, all of the values 
in the formula are known except for the coronary blood flow.  Hence, this formula 
enables the calculation of the coronary blood flow. 
 
1.7 Use of Doppler Echocardiography to Determine Coronary Blood Flow 
Another technique to measure coronary blood flow is needed to test the validity of the 
measurements by fluorescent microspheres that are planned for the research in this thesis, 
the velocity of blood flow can also be measured by Doppler echocardiography [20], and 
data from this second technique will be used in this thesis. 
An echocardiogram is a sonogram of the heart. This method uses standard 
ultrasound techniques to image two-dimensional slices of the heart. In addition to 
creating two-dimensional pictures of the heart or other structures in the cardiovascular 
system, an echocardiogram can also measure the velocity of blood at any arbitrary point 
using the Doppler shift measured in the returning ultrasound echo. Such Doppler 
echocardiography is often used to assess cardiac valve function and to look for any 
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abnormal fluid pathways communicating between the left and right sides of the heart.  It 
is also used to measure cardiac output by measuring the velocity of blood flow in the 
aorta. The Doppler effect (or Doppler shift) is the change in frequency of a sound wave 
when the source of the wave is moving with respect to the observer. Doppler 
echocardiography is a procedure which uses ultrasound technology to examine the 
velocities of motion of blood within and around the heart and also velocities of the heart 
tissue itself [37].  Doppler measurements of coronary blood velocity have been made in 
human subjects [20]. In addition to measurements in humans, transthoracic Doppler 
echocardiography has also proved to be reliable in measurement of coronary blood flow 
and coronary flow reserve in rat and mouse animal models [14-15].  
During our comparison study, pulsed-wave Doppler echocardiography will be 
used to determine coronary blood flow in rats. Pulsed wave (PW) Doppler systems use a 
transducer that alternates transmission and reception of ultrasound in a way similar to an 
M-mode ultrasound transducer [37]. One main advantage of pulsed Doppler is its ability 
to provide Doppler shift data selectively from a small segment along the ultrasound 
beam, referred to as the "sample volume". The location of the sample volume is operator 
controlled. An ultrasound pulse is transmitted into the tissues and travels for a given time 
(time X) until it is reflected back by a moving red cell. It then returns to the transducer 
over the same time interval but at a shifted frequency. The total transit time to and from 
the area is 2X. Since the speed of ultrasound in the tissues is constant, there is a simple 
relationship between roundtrip travel time and the location of the sample volume relative 
to the transducer face (i.e., distance to sample volume equals ultrasound speed divided by 
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round trip travel time). This process is alternately repeated through many transmit-receive 
cycles each second [10]. 
This range gating is therefore dependent on a timing mechanism that only samples 
the returning Doppler shift data from a given region. It is calibrated so that as the 
operator chooses a particular location for the sample volume, the range gate circuit will 
permit only Doppler shift data from inside that area to be displayed as output. All other 
returning ultrasound information is essentially "ignored" [10].  Hence, the blood velocity 
can be determined exclusively from one small region – in our case from one of the 
coronary arteries on the heart. 
 
1.8 Specific Aims of this Thesis 
This research study had four primary aims: 
1) To develop techniques for reliably measuring the number of fluorescent microspheres 
in a sample by using a commonly available laboratory fluorescent spectrophotometer. 
2) To develop techniques for reliably recovering 100% of microspheres in a tissue or 
blood sample by using the sedimentation method  
3) To test the ability of fluorescent microspheres to reliably measure coronary blood flow 
in rats by comparing results of the coronary blood flow reserve obtained using 
fluorescent microspheres with flow reserve measurements from Doppler 
echocardiography. 
4) To test the repeatability of fluorescent microsphere measurements of coronary blood 





DETERMINATION OF CALIBRATION CURVES 
FOR FLUORESCENT MICROSPHERES 
 
 
2.1 Principles of Fluorescence Spectrophotometry 
Fluorescence spectroscopy is a type of electromagnetic spectroscopy which analyzes 
fluorescence from a sample. Spectrophotometers use the principle of fluorescence 
spectroscopy. Spectrophotometers use the diffraction grating monochromators to isolate 
the incident light and fluorescent light to narrow ranges of wavelengths. They use the 
following scheme: The light (often from a broadband excitation source) passes through a 
filter or monochromator, and strikes the sample. A proportion of the incident light is 
absorbed by the sample, and some of the molecules in the sample fluoresce. The 
fluorescent light is emitted in all directions. Some of this fluorescent light passes through 
a second filter or monochromator and reaches a detector, which is usually placed at 90° to 
the incident light beam to minimize the risk of transmitted or reflected incident light 
reaching the detector. 
Various light sources may be used as excitation sources, including lasers, 
photodiodes, mercury-vapor lamps, and halogen arc lamps.  A laser only emits light 
within a very narrow wavelength interval, typically less than 0.01 nm, which makes an 
excitation monochromator or filter unnecessary. The disadvantage of this method is that 
the wavelength of a laser cannot be varied easily. A mercury vapor lamp is a line lamp, 
meaning it emits light only at several specific wavelengths. By contrast, a halogen arc 




Filters and/or monochromators are often used in spectrophotometers. The most 
common type of monochromator utilizes a diffraction grating; that is, collimated light 
illuminates a grating and exits with a different angle depending on the wavelength. By 
selecting the monochromator, light with an adjustable central wavelength and with an 
adjustable bandwidth can be used to excite the fluorescence in the sample and to limit the 
range of emitted light that will be detected. 
 
2.2 Biotek Instruments FL 500 Microplate Reader 
The specific spectrophotometer used in this research was contained within a microplate 
reader. They are widely used in research, drug discovery, validation, quality control and 
manufacturing processes in the pharmaceutical and biotechnological industry and 
academic research. The most common microplate format used in academic research 
laboratories or clinical diagnostic laboratories has 96-wells (arranged in an 8 by 12 
matrix) with a typical reaction volume between 100 and 200 µL per well. 
                                
 
Figure 2.1  Microplate reader used for fluorescence spectrophotometry [3].    




Figure 2.1 shows an example of the Bio-Tek Instruments FL500 Microplate 
Reader that was used to calculate fluorescence intensity from samples containing 
microspheres. It works on the following principle: a halogen lamp provides broadband 
illumination, which is then restricted to a narrower bandwidth by passing through an 
optical filter (the excitation filter). As a result of this optical excitation, the sample emits 
light (it fluoresces) and a second optical system (emission system) collects the emitted 
light over a different narrow band of wavelengths using a second optical filter (the 
emission filter).   This system collects and filters fluorescent light that was emitted at 90° 
to the incident excitation.  A photo-multiplier tube (PMT) quantifies the intensity of the 
resulting fluorescent light.  
The fluorescence filters are arranged in filter wheels: four excitation filters and 
four emission filters were provided.  The selection of filters available in the particular 
instrument used in this research is shown in Figure 2.2.  Each filter’s central wavelength 
and bandwidth (in nm) are specified. Spectral representations are shown on the next page. 
 
Figure 2.2   Selection of excitation and emission filters in BioTek FL500 [3].  









































Figure 2.4  Spectra of excitation filters available in the Bio Tek FL500. 
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2.3  Fluorescence Spectra of Commercial Microbeads 
As mentioned in Chapter 1, two suppliers (Molecular Probes and Triton Technology) 
provide microbeads that contain a range of fluorescent dyes.  The set of emission 
wavelengths for microbeads available from the supplier chosen for this research (Triton 
Technology) are shown in Figure 2.5. This figure was generated by fitting each emission 
spectrum to a skew-normal distribution.  Only by having such a variety of emission 
spectra – and limited bandwidth detectors – can multiple measurements of coronary 
blood flow be performed in the same experimental animal, since all injected beads 
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 Figure 2.5   Spectra of emitted fluorescence from a suite of commercial microbeads. 
                      Data for the peak frequency and bandwidth is obtained from [21]. 
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 Additional separation between the fluorescent signals from multiple varieties of 
beads embedded in a tissue sample can be obtained by taking advantage of the different 
excitation spectra for the fluorescent dyes in the beads.  Fluorescence is excited by 
photons of higher energy than the photons that are released during fluorescence.  By 
Planck’s law, these higher energy photons have higher frequency and thus shorter 
wavelength.  Some photon energies are better able to excite the fluorescent response of 
the dye, and this “efficiency” of excitation is expressed as the excitation spectrum for the 
fluorescent response.  For example, the excitation spectrum and the emission spectrum 
for yellow-green fluorescent microbeads is shown in Figure 2.6  The excitation spectrum 
–in blue – peaks at a lower wavelength (higher frequency and energy); in this case, the 
difference is 10 nm.  For the greatest excitation of fluorescence, the excitation should  
 
Figure 2.6 Excitation (blue) and emission (red) spectra for yellow-green dye [33].   
(Source: http://probes.invitrogen.com/media/spectra/8811h2o.jpg)  
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occur at wavelengths near this peak.  Note that the excitation efficiency falls off quickly 
for slightly longer wavelengths, while there is a greater extent of efficient excitation for 
wavelengths somewhat shorter than the best wavelength.  If the excitation of fluorescence 
is to be minimized when assaying for another variety of bead in a tissue sample, then the 
exciting wavelengths could be limited by a filter to wavelengths well away from the peak 
excitation “efficiency”. 
 Note that the spectrum of emitted fluorescent light is the same no matter what 
wavelength is used to excite the fluorescence [24]. This occurs because the variety of 
molecular vibrational modes excited when the dye molecule absorbs photons from a 
variety of wavelengths all die out quickly (within 10-14 to 10-10 sec).  Thus, the dye 
molecule quickly reduces its vibrational energy to a common minimal state before the 
fluorescent photon emission event occurs, an event which happens on a much slower time 
scale (10-9 to 10-7 sec) [24]. 
 
2.4 Choice of Fluorescent Dyes used in Microbeads 
The goal of this thesis was to measure coronary flow reserve. Thus, two successive 
measurements of coronary flow were required: (1) with the rat at a baseline resting state, 
when coronary flow will be minimal, and (2) during infusion of a vasodilator, when the 
coronary flow will be maximal.  Consequently, microbeads with two different dyes must 
be infused, and both varieties will remain simultaneously embedded in the tissue samples 
to be assayed by fluorescent spectrophotometry.  The particular pair of microbead dyes to 
use must be chosen so that their fluorescent signals can be essentially completely 
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separated by a judicious choice of the emission spectra of the dyes themselves and by the 
excitation and emission filters available in the spectrophotometer. 
Several experimental factors affected the choice of the two microbead dyes.  
Firstly, two of the chemical components used in processing the tissue and beads (the 
solvent 2-ethoxy-ethyl-acetate and the detergent Tween 80) both possess intrinsic 
fluorescent properties themselves, and their fluorescence is emitted in the blue part of the 
spectrum.  Consequently, microbeads with blue and blue-green dyes were not chosen for 
this project.  Secondly, photomultiplier tubes are generally less sensitive to longer 
wavelengths, so the dye having the longest emission wavelength (crimson) was not 
chosen so that the detection system would maintain the best possible sensitivity. The 
remaining three dyes were:  yellow-green, orange, and red.  As Figure 2.5 showed, the 
emission spectrum of the orange dye overlapped significantly with both of the other two.  
Hence, the orange dye was not chosen. 
The two selected microbead dyes were thus (1) yellow-green, and (2) red.  Their 
emission spectra did not overlap significantly.  Moreover, as the next section shows, the 
choice of excitation and emission filters made it possible that there was essentially 
complete separation between the fluorescent signals that would be measured from the two 





2.4 Choice of Excitation and Emission Filters 
Table 2.1 (below) reports the filter set chosen to be used when the fluorescence signal 
from either of the two chosen microbeads was to be measured.  The emission filter best 
matched to the yellow-green emission spectrum (Figure 2.5) is the second one from the 
left shown in Figure 2.3, which has maximum transmittance at 530 nm.  Similarly, the 
emission filter best matched to the red emission spectrum is the right-most one shown in 
Figure 2.3, which has maximum transmittance at 645 nm. The transmittance spectra from 
these two filters do not overlap, which enhances the separation of the fluorescent signals 
when both dyes coexist. 
The excitation spectrum for yellow-green dyed microbeads was shown in Figure 
2.6; 505 nm was the wavelength that most efficiently excited their fluorescence.  The 
excitation filter that best matched this excitation spectrum was the left-most one shown in 
Figure 2.4, which has maximum transmittance at 485 nm.  The excitation spectrum for 
red dye peaked at 580 nm, so the right-most filter shown there (peak = 590 nm) was 
chosen for this case.  Note that the spectra from the two excitation filters do not overlap, 
which – just as in the case for the emission filters – further enhances the separation of 
fluorescent signals.    
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2.6 Determination of Calibration Curve 
As explained in Chapter 1, the number of microbeads trapped in a tissue sample is the 
key measure used in the tracer method to determine coronary blood flow.   The 
fluorescent intensity of a tissue sample containing embedded microbeads provides a 
measure proportional to the number of microbeads contained in that sample.  However, 
both the proportionality constant and any offset must be determined by a calibration 
procedure before the fluorescent signal can be related quantitatively to the number of 
microbeads. 
Calibration requires measuring the fluorescence of solutions containing known 
numbers of microbeads. The most difficult part here is developing a reliable procedure 
that will accurately set the number of microbeads in a solution.  The starting point for this 
procedure is the known concentration of microbeads in the stock solution of microbeads 
provided by the supplier. The microbeads we used were packaged in a solution 
containing 1 million microspheres per milliliter. By accurately diluting this stock 
solution, and by accurately measuring out known volumes of these dilute solutions, a 
variety of samples containing known numbers of microbeads were prepared. 
The number of microbeads in the calibration samples should span the range 
anticipated to occur in the tissue samples. A large number of microbeads would be on the 
order of 10,000 to 20,000. The minimum number of microbeads that provides a reliable 
statistical estimate is on the order of 400.  Calibration standards spanning this range were 
prepared. 
Appendix I provides the detailed steps in the procedure used to prepare the 
calibration standards. Briefly, the first step was to prepare a 10:1 diluted solution of 
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microbeads.  This solution would thus have 100,000 microbeads per milliliter.  Since the 
sample size used in the wells of the 96-well plate is 100 µl, a sample drawn from this 
solution would contain 10,000 microbeads.  This is the maximum number that was used 
in a calibration standard. Subsequent 2:1 dilutions then produced standards containing: 
5000, 2500, 1250,  625,  and 312 microbeads.  These standards spanned the range over 
which calibration was performed. 
 During the dilution and sample loading procedure, extreme care was taken to 
maintain the microspheres in solution and to prevent clumping and aggregation of 
microspheres. A small amount of detergent (Tween 80) was used in the diluting solutions 
to minimize clumping and aggregation, and solutions were often agitated vigorously in a 
vortex mixer. 
 Accurate measurement of solution volumes was also required. This was 
accomplished using well-calibrated mechanical pipettes, which are common in 
biochemical laboratories.  Following the proper pipetting procedure was also important. 
 
2.7 Results of Calibration Curves 
Five replicate determinations of a calibration curve were performed for each of 
the two varieties of microbeads used in this study.  Table 2.2 and Figure 2.7 provide 
typical results for one such calibration curve, which was performed on solutions 
containing yellow-green microspheres. Appendix II provides similar detailed results for 
all of the 10 calibration curves. Each calibration curve maintained a tight linear relation 
between microbead number and fluorescence intensity. The R2 values for linear 
regression were all above 0.9936, and most were above 0.9990. 
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            Figure 2.7  Typical calibration regression line for yellow-green microspheres 
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However, the replications of the calibration curves did not all produce slopes of 
the regression lines that were in close agreement with one another (see Figures 2.8 and  
2.9).  Since each individual regression line was rather linear without much scatter, it 
seemed likely that the major contribution to the disagreement among regression lines 
arose due to experimental uncertainty in the first step of the calibration procedure.  The 
stock solution may not have been sufficiently well-mixed when the sample was 
withdrawn, or there may have been some error in withdrawing a 1 ml volume into a 
plastic syringe, since a calibrated pipette could not perform this step.  
 
2.8 Averaging calibration curves 
To overcome the uncertainty in the regression coefficient, the results from the 5 replicate 
calibration curves were averaged together for each variety of microbead. Averaging was 
thought to reduce the uncertainty introduced during the initial microbead withdrawal 
from the stock solution.  Tables 2.3 and 2.4 on the next pages report the averaging 
process.  Each averaged relationship then became the standard calibration curve for that 
color microsphere, which was used to convert the fluorescence from a tissue sample into 
the number of microspheres contained within that sample. 
The final calibration curves were: 
For yellow green microspheres: If = 0.9256 Ns   - 4.9102 
 
For red microspheres:   If = 1.0954 Ns   + 0.8414 
 
where If is the fluorescent intensity and Ns is the number of microspheres.   
Note that red microspheres produced slightly more fluorescence intensity per sphere.  
The offset values were not statistically different from zero. 
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Calibration of Yellow-Green Microspheres 
   Table 2.3 Summary of calibration for yellow – green microspheres 





1 1.1455 + 4.4194 0.9992 
2 0.9229 -92.562 0.9992 
3 0.8696 -36.541 0.9998 
4 0.9188 -30.379 0.9976 
5 0.774 +130.56 0.9974 
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Figure 2.8 Linear regression calibration curves for yellow – green microspheres 
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Calibration of Red Microspheres 
Table 2.4 Summary of calibration for red microspheres 
Trial Number  Slope of Regression Intercept of 
Regression 
R-squared 
1          1.1084          -104.79       0.9993 
2          0.9083          -137.87       0.9966 
3          1.1498           181.72       0.9990 
4          1.0897           49.578       0.9936 
5          1.2234            12.204       0.9996 
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EXPERIMENTAL TECHNIQUES TO DETERMINE CORONARY BLOOD 
FLOW IN RAT ANIMAL MODEL 
 
 
When appropriately sized microspheres are used, regional blood flow is proportional to 
the number of microspheres trapped in the organ of interest. 
 
3.1 Source of Fluorescent Microspheres 
 
Triton Technology (San Diego, CA) and Molecular Probes (Eugene, OR) are the two 
major companies manufacturing fluorescent microspheres used in biomedical research 
and various other applications. For our procedures we have used fluorescent 
microspheres sold by Triton Technology. Triton Technology sells two types of 
fluorescent microspheres: Triton Technology Dye-Trak 'F' fluorescent microspheres and 
the FluoSpheres® manufactured by Molecular Probes. We have used Molecular Probes 
Fluospheres (with Triton Technology packaging) for our experiments. Fluospheres are 
non-radioactive fluorescent microspheres for high sensitivity measurement of regional 
blood flow quantified by spectrofluorometry. Each 20 ml bottle contains 20 million 
spheres, 15 µm in diameter, in a saline solution, with 0.05% Tween 20 as a detergent to 








3.2 Calculation of Number of Microspheres for Injection 
 
A minimum of 400 – 500 microspheres are needed per tissue piece to be 95 % confident 
that flow measurement is within 10% of the true value [39]. For regional blood flow 
measurements, the total number of microspheres to be injected into the whole animal 
must be calculated to assure that a sufficient number reach the particular organ of 
interest.  
The following equation estimates the minimum total number of microspheres 
needed per injection [39]: 
                                               Nmin = 400 (n) * [ Qtotal  / Qorgan ]                                      (3.1) 
Where, Nmin = minimum total number of microspheres needed for injection 
             n = total number of organ pieces in the organ with the smallest blood flow 
             Qorgan = total blood flow through an organ of interest with the smallest blood flow 
            Qtotal   = cardiac output 
Applying this equation to our procedure, we first must estimate the cardiac output 
expected in the experimental animals we used.  The cardiac index observed in Sprague 
Dawley rats of the same age and weight as we used is approximately 350 ml/min/kg [22]. 
Considering the approximate weight of the rats we used to be 400g,  
Cardiac Output = Cardiac Index * Mass of an animal 
                                                     = (350 * 400) / 1000 
                                                     = 140 ml/min 
Since our organ of interest is the heart, which has a relatively large blood flow, the 
“organ” with the smallest blood flow will actually be the “virtual organ” created by the 
reference withdrawal of blood.  Since we will withdraw the reference blood flow at a rate 
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of 0.5 ml/min, the estimate of the minimum total number of microspheres needed per 
injection is: 
Nmin = 400 (n) * [Qtotal  / Qorgan ] 
                                                     = 400 (1) * [140 / 0.5]  
                                                     = 112,000  
Where, n = number of organ pieces = reference blood flow sample = 1 
    Qorgan  = reference blood flow = 0.5 ml/min 
     Qtotal   = Cardiac output = 140 ml/min 
Thus, a minimum of 112,000 microspheres per injection was needed for our 
procedure. We have injected 0.5 ml volume of microsphere solution, which contains 
500,000 microspheres. Thus, the volume used for our procedure was quite enough to trap 
a sufficient number of microspheres in the tissue and blood samples. Usually double the 
minimum number of microspheres are injected to make sure that low flow organ pieces 
have an adequate number of microspheres [39].  Our procedure met this guideline as 
well.  
 
3.3 Preparation of fluorescent microspheres for injection 
 
Aggregation is a major problem associated with fluorescent microspheres. This might 
clog a blood vessel, resulting in damage which might result in the death of an animal. 
Aggregation of the particles is prevented by the use of small amounts of detergent in the 
injectate, or by suspending them in a solution containing macromolecules. A detergent 
named Tween 80 is normally added to the solution to prevent aggregation and clumping 
together of microspheres. However, the concentration of the detergent cannot be too high, 
otherwise it could damage the lipids in the cell membranes of endothelial cells or blood 
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cells. Therefore, we used a concentration of 250 µl. During the microsphere injection 




1) Remove the bottle from the refrigerator and check supernatant solution. Ideally, the 
solution should stay clear due to the presence of thimerosal in it. Thimerosal is a 
bacteriostat which prevents the growth of any bacteria or fungi thus preventing cloudy 
fluid and contamination.  
 
2) Vortex the bottle vigorously for 5 – 15 seconds using a vortex mixer. Vortexing 
ensures proper mixing of the solution thus preventing aggregation of microspheres. 
 
3) Place the bottle in an ultrasonic water bath for at least 30 minutes to allow dispersion 
of microspheres. This allows proper mixing of microspheres with the liquid solution. Be 
careful with the sonication time as the heat generated might melt the microspheres. 
 
4) Continue to sonicate the microspheres until the sample is used for the procedure. 
 
5) Just prior to injection, vortex the vial of microspheres again and withdraw the desired 
volume of 0.5 ml immediately. The injected volume drawn into syringe should then be 
injected immediately into the body of animal. If injection time is delayed, vortex the 
microspheres thoroughly again. 
 
6) Injection time varies for each procedure and should be determined prior to injection. 
Injection to left heart takes a short time (normally 5 – 15 seconds). In our procedure, 
injection time is 5 seconds. 
 
7) Slow and steady injections allow for proper mixing of microspheres with the blood in 
the left ventricle. 
 
8) After injection, flush the dead space of the catheter thoroughly with saline and change 
the stopcock to avoid contamination of subsequent injections. 
 
 
3.4 Reference blood flow sampling 
 
A reference blood flow sample allows calculation of regional flow in ml / min. The 
catheter used for the withdrawal of sample should be accurately positioned so that a 
blood sample containing well mixed microspheres can be obtained. Blood samples should 
33 
 
be obtained as close to the organ of interest as possible without interfering too much with 
the normal blood flow. The reference withdrawal pump must be accurately calibrated at 
0.5 (ml/min) so that reference blood is withdrawn at a uniform preset rate for a period of 
2 minutes. Although glass syringes and containers would have been preferred as they 
decrease microsphere loss by avoiding adhesion to walls, which could occur in case of 
plastic syringes or containers, we found that use of plastic syringes was adequate and did 
not result in loss of microspheres. 
  Researchers say that 15% of blood volume is the maximum that can be taken out 
at a stretch from the body, say during donation of blood. More than 15% results in a 
significant loss of arterial pressure and might result in some heart problems.  
  Since the animals used in our procedure weigh 350-450g, withdrawal of minimum 
reference blood should be calculated.  For a rat weighing 350g, blood mass = 8% of body 
mass = (0.08)(350g) = 28 g.  This equates to approximately 28 ml of blood since the 
density of blood is only slightly greater than that of water. 
If 2 ml is withdrawn as reference blood during microsphere procedure, then it 
accounts for 7% loss of blood from the body which is quite tolerable and should not 
create a bad impact on the condition of the animal. 
Similarly, for a rat weighing 450g, its blood volume is estimated to be 36 ml.  If 2 
ml is withdrawn as reference blood during microsphere procedure, then it accounts for 
5% loss of blood from the body of animal which is tolerable and does not affect the 
condition of animal. 
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Therefore, withdrawal of 0.5 (ml/ min) for a period of 2 minutes results in 5% - 





Male Sprague Dawley rats, body weight 350 – 450 g, age 8 - 12 weeks, were housed in 
separate cages and maintained in a temperature regulated environment. The animals were 
used as described in a protocol approved by IACUC committee (Institutional Animal 
Care and Use Committee) of UMDNJ – Newark. This institution is accreditated by 
AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care) 
International program. Two animals were used. Both were subjected to injections of 
Triton Technology 15 µm diameter fluorescent microspheres of two different colors: 
yellow-green microspheres used for baseline measurements and red microspheres used 




 Surgery was performed by an experienced doctoral student, Xin Zhao, in the department 
of Cell Biology and Molecular Medicine at UMDNJ – Newark, trained to perform 
cardiovascular surgery on rats.  An anesthetic technique that has minimal effect on the 
heart rate is essential. The following anesthetic regime resulted in heart rates that were 
close or slightly below the rate for an alert, resting rat and allowed excellent animal 
recovery. Anesthesia was induced with a mixture of ketamine (70mg/ kg) and xylazine 
(7mg/ kg) administered intramuscularly. Since the experimental procedure was not for a 
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long duration, no supplemental anesthesia was needed. While anesthetized, the rats 
underwent several cannulation procedures. 
 
Figure 3.1 Rat model showing cannulation in left ventricle and femoral artery 
 
The left ventricle was cannulated via the right carotid artery by a polyethylene 
catheter (RPT040 -- .040 OD” x .025 ID) to observe left ventricular pressure and to 
subsequently inject microspheres and adenosine into the left ventricle. By observing 
changes in the pressure waveform from an arterial pattern to a ventricular pattern, it could 
be determined when the cannula tip was in the ventricular lumen. The right femoral 
artery was cannulated by a similar catheter (RPT040  .040 OD” x .025 ID) and was 
advanced into the abdominal aorta to monitor arterial pressure  and also obtain a sample 
of blood flow. During blood flow sampling, this catheter was connected to a Harvard 
Apparatus syringe pump for the withdrawal of reference blood sample containing 
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microspheres that are adequately mixed. Right jugular vein was cannulated by MRE 040 
.40OD" X .025 ID catheter for the injection of saline to restore blood volume after each 
microsphere injection and sampling procedure.  
  The entire procedure takes about 1.5 – 2 hours. The animals were then allowed 
to recover for 2-3 hours after the completion of cannulation surgery. After the normal 
hemodynamic condition of the animal was recovered, a subsequent microsphere injection 
procedure could be performed. 
 
3.7 Procedure for Injection of Microspheres 
 
Systemic hemodynamic and regional blood flow was determined using 15 micrometer 
diameter fluorescent microspheres (FluoSpheres® Triton Technology, San Diego, CA, 
USA (20 million 15 micron spheres per 20 ml vial)). Briefly, two different colors of 
fluorescent microspheres were used. The colors of microspheres were selected as 
previously described to avoid spillover between the colors. Yellow-green and red colors 
have been selected for our experiment. Yellow-green microspheres are used for baseline 
measurement and red microspheres are used for measurements after infusion with 
adenosine. 
The procedure is as follows:  
 
1) Shake well the bottle containing microspheres of desired color and place it in an 
ultrasonicator. This allows proper mixing of microspheres and prevents aggregation of 
microspheres. 
 
2) The bottle containing microspheres are sonicated until the desired amount is removed 
and without wasting any time, the microspheres are injected directly into the body of 
animal. 
 
3) Two Harvard apparatus infusion pumps were used for procedure: One pump is used 
for the injection of adenosine at the rate of 0.15 (mg/kg/min), second pump is used for the 
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withdrawal of reference blood sample at the rate of 0.5 (ml/min) for a period of 2 
minutes. 
 
4) Four 1cc plastic syringes were used in infusion pumps: two syringes were used for 
collecting blood and the remaining two were used for injection of microspheres. Heparin 
coated syringes were used for the collection of blood samples to avoid the clot of blood 
once it is collected in a syringe. Also, once collected in heparin coated syringe, it then 
becomes easy to transfer in any other container without any clot observed.  
 
5) The diameter for the syringe was set to 4.78 mm. 
 
6) The withdrawal pump was calibrated at the predetermined withdrawal rate, including 
the catheters, extension tubing and syringes that would be used for the reference 
withdrawal.  
 
7) The syringes would be connected to the withdrawal pump to the catheters and the 
extension tubing so that everything is set up for withdrawing the reference blood sample. 
The stopcock is turned off to avoid clotting of blood into the catheter dead space until 
injection.  
 
8) Four paper pins were placed, one at each corner of surgical board, that hold each limb 
of the animal. 
Horizontal distance between the pins is 15cm. 
Vertical distance between the pins is 12cm. 
 
9) Core temperature of the animal was monitored with a rectal probe and maintained at 
36.5 degree Celsius with an automatic heating lamp.  
 
10)  The hemodynamics of the rat is checked for its normal condition before the injection 
of microspheres. 
 
11)  Yellow-green microspheres are injected first into the body of animal to determine 
baseline measurements and then red microspheres are injected to determine 
measurements after infusion of adenosine. 
 
12)  Once the microspheres had been drawn into the injection syringe, the withdrawal 
pump was started and made sure that the flow was smooth without any clot. 
 
13)  Now, a volume of 0.5 ml of yellow green fluorescent microspheres was injected over 
a period of 5 seconds followed by the flush of saline.  
 
14)  Simultaneously, the reference blood sample was withdrawn for a total interval of 2 
minutes, 1 minute each for both the color of microspheres. At the end of the withdrawal, 
the pump was turned off, the stopcocks were opened and the blood remaining in the 




15)  The reference blood was then transferred from heparinized syringe into 
polypropylene tubes for further processing. Also, the syringes and the extension tubing 
were washed with 2% Tween 80 and this solution was then added to the blood samples to 
avoid any loss.  
 
16)  Adenosine which works as a potent dilator of arterioles was then infused into the left 
ventricle via the catheter in the left ventricle.  
 
17) After the rat’s hemodynamic state had stabilized under the adenosine infusion, 0.5 ml 
volume of red microspheres was injected over a period of 5 seconds followed by the flush 
of saline.  
 
18)  The reference blood sample was collected in heparinized syringe which is then 
transferred to polypropylene tubes for further processing. 
 
 
This injection procedure produced two sets of microspheres in each rat. At the end 
of the procedure, the rats were euthanized with an overdose of anesthetic. The heart was 
removed, weighed and placed in a polypropylene tube. The reference blood sample and 
heart tissue were then digested by 2.3 M ethanolic KOH and 0.25 % Tween 80 for a 
period of 48 hours. At the end of digestion, microspheres were recovered by the 
sedimentation method and the microsphere dye was extracted by using 3 ml of 2- 
ethoxyethyl acetate, that dissolved the plastic spheres and so released the fluorescent dye 











EXPERIMENTAL TECHNIQUES TO RECOVER MICROSPHERES 
FROM TISSUE AND BLOOD 
 
4.1 Three Alternative Methods to Separate Microspheres From Tissues 
Microspheres must be physically separated from the tissue or blood in order to quantify 
the number of microspheres in each sample. 
There are three practical methods to recover microspheres from digested tissues 
[39]: 
1) Negative pressure filtration 
2) Polyamide woven filtration devices (manufactured by Perkin Elmer) 
3) Sedimentation 
All three methods will be described below, along with the disadvantages of both 
the filtration methods. Ultimately, the sedimentation method was the one chosen for use 
in this research. The details of the sedimentation method will be presented in other 
sections in this chapter. The initial key step in all three procedures is digestion of tissue 
or blood sample. All methods use ethanolic KOH, a very powerful digesting solution.  
 
4.2 Negative Pressure Filtration 
In the case of the negative pressure filtration technique, the volumes and concentrations 
of solutions are not critical. Negative pressure filtration works on digested heparinized 
blood samples and solid tissue. After the samples have been digested with KOH, the 
microspheres are physically separated by negative pressure filtration.  Filtration is usually 
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performed with a combination of a Poretics filtration device using Poretics polycarbonate 
filters [39].  
Disadvantages:  
1) Digested tissue samples should not stand unfiltered for a long period of time since the 
fat in them may solidify and this may result in damage to the sample. 
 
2) The method is labor intensive. 
 
3) There may be microsphere loss when the tissue sample is transferred from one vessel 
to another or if the filter fails to trap all microspheres. 
 
4) The filters must be changed every time for each new sample. This may increase the 
expense.  
 
5) The filtration process may proceed slowly as the filter might become clogged with 
microspheres or tissue debris. 
 
4.3 Polyamide Woven Filtration Devices 
These devices are specifically made to isolate fluorescent microspheres from CPD  
(citrate phosphate dextrose) anticoagulated blood or digested tissues [39]. Each tissue 
sample is digested, filtered and the fluorescent dyes are extracted in a single container. 
The devices are polypropylene and consist of three stages. Digestion is done with 
ethanolic KOH.  
Disadvantages: 
1) These devices offer limitations with heparin containing blood samples.  
 
2) There may be microsphere loss when the tissue sample is transferred from one vessel 
to another or if the filter fails to trap all microspheres. 
 
3) Digestive tissue samples should not stand unfiltered for a long period of time since 
the fat in them may solidify and may result in damage to the sample. 
 





Sedimentation is the tendency for particles in suspension to settle out of the fluid in 
which they are entrained, and come to rest against a barrier. This is due to their motion 
through the fluid in response to the forces (gravitational force or centrifugal force or 
electromagnetic force) acting on them.  
Sedimentation of microspheres based on centrifugal force (as in a centrifuge) is 
possible if the specific gravity of the solution is less than that of microspheres. 
Microspheres have a density of 1.05 g / ml, which is close to the density of red blood 
cells and myocardial tissue.  Ethanolic KOH has a density on the order of 0.8 g / ml, 
which is much smaller compared to that of microspheres.  
Sedimentation is a 7 day procedure. It is the most effective procedure and also it 
is cost effective. The chemical solutions can be easily prepared in the laboratory, and the 
polypropylene tubes used for the procedure are inexpensive and available in bulk. The 
steps in the procedure are summarized in Figure 4.1 After digesting the tissue with 
ethanolic KOH, the procedure consists of 3 successive stages of centrifugation 
interspersed by washes with specific solutions or buffers.  As a final step, a chemical is 
added (2-ethoxy-ethyl-acetate) that dissolves the plastic microspheres and thus releases 
the fluorescent dye into solution.  A final centrifugation (not shown in Figure 4.1) 
separates this solution from the remnants of the plastic microspheres.  A sample of this 




        
Figure 4.1 Sedimentation procedure for fluorescent microspheres [39]   
(Source: Manual for using fluorescent microspheres to measure regional organ perfusion, accessed on 
March, 2011)  
                                  
 
4.5 Importance of Accurate Fluid Volumes 
The ratio of the number of microspheres contained in the heart tissue versus the blood 
sample (N heart  / N blood ) is very important for accurate determination of coronary blood  
flow. As per the procedure, 3ml of 2-ethoxy-ethyl-acetate is added to each heart and 
blood sample and then the samples are placed in the dark for 5 days. 2-Ethoxy-ethyl- 
acetate dissolves the microspheres, releasing the fluorescent dye from the microspheres. 
On the last day of the procedure, the samples are centrifuged and 100 microliters of the 
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Measurement of coronary blood flow depends on the ratio of (Nheart / Nblood ).  The 
more accurate the ratio, the more accurate is the value of blood flow. Heart and reference 
blood samples from each rat were analyzed for fluorescence intensity measurement. In 
the sedimentation procedure, 3 ml of 2-ethoxy-ethyl-acetate were used for each sample. 
2-ethoxy-ethyl-acetate releases fluorescent dye by dissolving the microspheres. Carefully 
pipetting out the 3 ml amount of  2-ethoxy-ethyl-acetate from the stock bottle is essential 
for accurate measurement. In our procedure, 3 ml was accurately removed from the bottle 
using an automated pipette.  In addition, carefully extracting precisely 100 microliters of 
the supernatant containing the fluorescent dye is also essential. This amount was 
carefully pipetted out using a 200 microliter pipette. If the volume of 2-ethoxy-ethyl- 
acetate is not accurate, the concentration of fluorescent dye in the resulting supernatant 
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could vary, which would vary the number of microspheres obtained when 100 microliters 
of the supernatant is extracted for measurement. Similarly, the volume of supernatant 
must be reproducibly pipetted out, so that the ratio of the number of microspheres is the 
same as the ratio of dye concentrations in the supernatant fluids form tissue and blood 
samples.  
 
4.6 Solutions Used in the Sedimentation Method 
The six different solutions used throughout the sedimentation procedure are as follows:  
1) 2.3 M Ethanolic KOH with 0.5 % Tween 80  
 100 ml of ethanol is added to the glass beaker containing a mixture of 3 gm KOH 
and 0.5 gm Tween 80. The solution is stirred continuously for approximately 20 minutes 
until a clear solution is obtained. Tween 80, a viscous and water soluble yellow fluid, is 
used as an emulsifier. KOH, since it is obtained in pellet form, needs to be stirred 
properly to ensure proper mixing. Freshly made KOH solution, warm due to the 
exothermic reaction, aids in tissue digestion. 
2) Internal standard ( This is optional ) 
The microspheres are vortexed and sonicated for 30 seconds and then 1ml of solution is  
immediately withdrawn using a sterile syringe. This 1ml of solution is added to 100 ml of 
0.25% Tween 80. A magnetic stirrer is used to stir the solution continuously until its use. 
3) 1% Triton X-100 




4) Distilled water phosphate buffer  
5.88 grams of monobasic KH2PO4 is added to 200 ml distilled water. 22.9 grams of 
dibasic KH2PO4 is added to 800 ml distilled water. The two solutions are then mixed 
together. 28.6 ml of this combined solution is added to 1000 ml of distilled water and 
stirred until they mix really well. This produces a distilled water phosphate buffer, which 
is a solution used for rinsing.  
5) 0.25 % Tween 80 
2.5 grams of Tween 80 is added to 1 liter of distilled water and stirred continuously with 
a magnetic stirrer until in use. 
6) 2 – Ethoxy-ethyl-acetate ( also known as Cellosolve acetate ) 
This is a solution used to dissolve microspheres and release dye. 2–ethoxy-ethyl-acetate 
should not be confused with ethyl cellosolve, since that doesn’t dissolve the 
microspheres.  
 
4.7 Calculation of Centrifuge Rotation Rate 
During the sedimentation method, a centrifugal acceleration equivalent to 2000 times the 
acceleration of gravity (i.e., 2000Gs) had to be achieved. The faster the centrifuge rotates, 
and the longer the radial distance to the sample being centrifuged, the stronger the 
centrifugal acceleration. The calculations below were performed to determine the rotation 
rate required to achieve 2000Gs for the specific centrifuge and sample tubes that were 
used in this research.  
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A centrifuge is a laboratory instrument driven by electric motor that puts an object 
in rotation around a fixed axis and thus induceses a centrifugal force perpendicular to the 
axis. The centrifugal acceleration generated by the instrument is such that it causes more 
dense substances to separate out along the radial direction at the bottom of the tube. The 
centrifuge consists of rotating units, called the rotor, which has its own specifications. 
We used a Beckman Coulter 366802 – Allegra 6 Benchtop Centrifuge for our 
procedure. The centrifuge consists of GH–3.8 / GH–3.8A rotors which have the 
following specifications:  1) minimum radius = 86mm;  2) maximum radius = 204mm; 
3) maximum allowable rotation rate = 3750 rpm. 
During circular motion, the centrifugal acceleration is the product of the radius 
and the square of the angular velocity. The acceleration is generally measured in terms of 
“G”, which is also called the relative centrifugal force. One “G” is equal to the 
acceleration due to gravity at the earth’s surface, which equals  9.8  m/s2 .   
In the Beckman centrifuge that we used, the radius to the bottom of the centrifuge 
tube (where the denser sample will collect) was measured.  We set the rotor to the 
minimum distance from the axis of the centrifuge.  The radius to the edge of rotor thus 
was 8.6 cm.  The polypropylene 15 ml centrifuge tubes that we used extended 10 cm 
beyond the rotor.  Thus, the total radial length to the sample ( r ) = 18.6 cm.  
In our procedure, we desired to create an acceleration of 2000 G’s. The angular 
velocity ( ω ) required to produce this acceleration ( A ) was calculated as follows: 
A = ω2 r 
2000 (9.8 m/s2) = ω2 (0.186 m) 
ω = 324.6 rad / sec 
47 
 
Angular velocity converts to rotational frequency according to the following formula: 
ω = 2πf 
Thus, the required rotational frequency f = 51.7 rotations/sec, which is 3100 rpm.  This 
rotation rate is within the range of rotation rates allowed by the manufacturer’s 
specifications. 
 
4.8 Details of Sedimentation Procedure 
The procedure takes a total of 8 days. The animal was euthanized on the same day soon 
after the microsphere injection procedure. The heart was removed, and the left ventricle 
was separated from the rest of the heart for recovery of fluorescent microspheres. 
Polypropylene 15 ml centrifuge tubes with tightly fitting caps were used.  
Day 1  
1) The tubes fitted with their caps and the tissue and blood samples were weighed. Each 
cap should be paired with its tube so that the weight of the capped tube is reliable.  
 
2) 8 ml of ethanolic KOH was then added. Ethanolic KOH should be carefully poured 
into the tubes since outside spillage can remove writing on the tubes. Also, ethanolic 
KOH is extremely caustic in nature and can cause burns on skin. 
 
3) The solution was vortexed for a period of 20 seconds. 
 
4) The tubes were then incubated for a period of 48 hours at 50 degrees centigrade at a 
speed of 150 revolutions per minute. 
 
Day 2  
Each sample was removed from the incubator and vortexed for 20 seconds per tube. The 





Day 3  
1) Each sample was removed from the incubator and vortexed for about 30 seconds until 
the particles were re-suspended. Just before the next step, each sample was vortexed 
again for 5 more seconds. 
 
2) The samples were centrifuged at 3100 rpm for about 20 minutes. 
 
3) All but 1.5 ml of supernatant fluid was removed using a Pasteur pipette attached to 
suction with a trap.  This supernatant was discarded. 
 
4) Approximately 8 ml of 1% Triton X-100 solution was added to each sample, and then 
each sample was vortexed for about 30 seconds. 
 
5) The samples were centrifuged at 3100 rpm for about 20 minutes. 
 
6) All but 1.5 ml of supernatant fluid was removed using a Pasteur pipette attached to 
suction with a trap, and the supernatant was discarded. Suction was done carefully to 
avoid loss of microspheres. 
 
7) 7 ml of distilled of distilled water phosphate buffer was added to each tube, and each 
tube was vortexed for about 30 seconds until all particles were suspended in the solution. 
8) The samples were centrifuged at 3100 rpm for about 20 minutes.  
 
9) All but 1.5 ml of supernatant fluid was removed using a Pasteur pipette attached to 
suction with a trap, and the supernatant was discarded. 
 
10) Exactly 3 ml of 2-ethoxy-ethyl-acetate was then added to each sample, and each was 
vortexed for about 30 seconds until the particles were well suspended in the solution. 
 
11) The samples were then placed in a dark room away from light for 5 days. 
 
Day 5  
The samples were taken out from the dark room and vortexed for about 20 seconds each 
until the pellet broke up. 
Day 8   
1) The samples were removed from the dark room and vortexed vigorously for about 30 
seconds each until the pellet broke up. 
 
2) The samples were centrifuged at 3100 rpm for about 20 minutes. 
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3) Exactly 100 µL of supernatant fluid containing the dye released from the 
microspheres was then used for fluorometry. 
 
4) The blood and tissue samples were then measured for fluorescence on the same day.  
 
4.9 Advantages of the Sedimentation Method 
1) Polypropylene 15 ml centrifuge tubes are used, which are available in bulk in a 
routine chemistry lab. 
 
2) The tubes are inexpensive as compared to the filters. 
 
3) The procedure although time consuming, is not labor intensive. 
 
4) There is minimal loss of fluorescent microspheres, since they do not have to be 
transferred from one vessel to another.  
 
5) The sedimentation procedure starts on the same day soon after the microsphere 



















OF CORONARY BLOOD FLOW AND CORONARY RESERVE IN RATS 
USING FLUORESCENT MICROSPHERES 
 
5.1 Summary of Experimental Protocol 
Two male Sprague-Dawley rats, body weight 414 and 395 g, both age 12 weeks, were 
used for the microsphere injection procedure, as described in detail in Chapter 3. Briefly, 
each rat was cannulated with multiple catheters under a mixture of ketamine and xylazine 
anesthesia administered intramuscularly. One catheter was introduced through the right 
carotid artery into the left ventricle for injection of fluorescent microspheres and 
adenosine. The second catheter was introduced through the right femoral artery and 
advanced into the abdominal aorta for collection of the reference blood sample during 
injection of fluorescent microspheres into the circulation of the rat. The third catheter was 
introduced into the right jugular vein for infusion of saline following the withdrawal of 
each reference blood sample. After the 1.5 – 2 hour cannulation procedure, the rat was 
allowed to recover back to its normal hemodynamic condition.  
Soon after the recovery, the rat was subjected to the microsphere injection 
procedure. Normal hemodynamic conditions were mandatory before proceeding with the 
microsphere procedure. Microspheres which fluoresced at two different colors were used 
for the procedure:  (1) yellow-green microspheres were used for baseline measurements, 
and (2) red microspheres were used for measurements of coronary reserve made during 
infusion of a vasodilator (adenosine). During both microsphere injections, reference 
blood containing a sample of the injected microspheres was collected at a preset rate of 
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0.5 ml/min for duration of 2 min. Table 5.1 presents the timeline of the experimental 
procedures applied during a typical microsphere injection procedure (Rat 2 in this case).  
Table 5.1 Timeline of a typical experiment 




      
(min:sec) 
     
PAGE 
 
    (from  





      00:00   1       Start data recording after finish instrumenting the 
rat 
      05:19      72       Baseline data before injection of yellow-green 
microspheres 
      05:29      74          Begin arterial blood withdrawal for reference blood 
flow                 
      05:48      78     Start injection of yellow-green microspheres into LV 
    07:29      ---     End arterial blood withdrawal for reference flow 
           10 minute recovery period following first    
microsphere injection 
      16:06      153        End recovery period;  Begin adenosine infusion 
      16:26      157        Adenosine begins to affect global hemodynamic 
measurements 
      24:38      268       Steady-state data recorded under effect of 
adenosine 
      24:59      272       Begin arterial blood withdrawal for reference flow 
with adenosine 
      25:30      279      Start injection of red microspheres into LV 
      26:59 -    ---       End arterial blood withdrawal for reference flow 
        5 minute recovery period following microsphere 
injection 
      31:40      287       Last data recorded after recovery from second 
microspheres 
 
NOTES:    
(1)  Elapsed time began at 09:55:26 am on May 25, 2011.  This was experiment #2. 
(2)  Page numbers shown in bold are included as figures in this chapter. 
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Hemodynamic parameters were recorded throughout the entire procedure. Heart 
rate, arterial and left ventricular pressures, and the rate of rise of left ventricular pressure 
(dp/dt) were monitored during baseline conditions and following vasodilation during 
adenosine infusion. 
Figure 5.1 presents the strip chart record of left ventricular pressure (LVP), 
abdominal aortic pressure (MAP) and the derivative of LVP (dP/dt) during the baseline 
state before injection of any microspheres. In Figure 5.2, data was recorded when the 
arterial catheter was disconnected from the pressure transducer and switched to the pump 
that withdraws the reference blood flow, leaving the arterial pressure transducer open to 
atmosphere (MAP = 0). During the time period shown in Figure 5.3, the left ventricular 
catheter was disconnected from its pressure transducer and switched to the infusion 
syringe, so that the infusion of microspheres into the left ventricle began.  Note that the 
withdrawal of the reference flow continued (MAP = 0).  
After allowing 10 minutes for the cardiovascular system to re-stabilize following 
the initial microsphere injection, Figure 5.4 shows a strip chart record of the 
hemodynamic conditions just before the adenosine infusion began. The steady adenosine 
infusion continued at a rate of 0.15 mg/min per kilogram of animal mass. Because 
adenosine exerts a vasodilator influence throughout the systemic vasculature, arterial and 
ventricular systolic pressures were lower when a steady state was eventually achieved 




Figure 5.1 Hemodynamic parameters at baseline in Rat 2. 
 




Figure 5.2 Hemodynamic parameters during the beginning of reference blood flow 




Figure 5.3 Hemodynamic parameters at beginning of injection of yellow-green  
microspheres into left ventricle. 
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    Figure 5.5 Hemodynamic parameters after attaining steady state under adenosine 
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Tables 5.2 and 5.3 summarize the hemodynamic conditions observed during 
microsphere injections in Rats 1 and 2.  The baseline conditions were both within the 
normal range for rats, although Rat 1 was slightly hypotensive, while Rat 2 was slightly 
hypertensive.  As expected, infusion of the vasodilator adenosine reduced vascular 
peripheral resistance, so that mean arterial pressures fell by ~25% in both cases.  This 
percentage decline in arterial pressure is within the range typically seen during adenosine 
infusion in rats [22].  The decline in left ventricular dp/dt in Rat 1 was somewhat atypical 
compared to what is commonly reported during adenosine infusion in rats [22].  The fall 
in heart rate in Rat 2 was also somewhat atypical. 
 
Table  5.2   Hemodynamic conditions during microsphere injections in rat 1 




































    283     81      4731       85       54      64 
 
Table  5.3   Hemodynamic conditions during microsphere injections in rat 2 




































    203     101      5623       100       63     79 
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After the microsphere injection procedures, the rats were euthanized with an 
overdose of anesthetic.  The chest was opened and the heart was removed.  The atria, 
great vessels, and right ventricular free wall were all trimmed away, so that only the left 
ventricle (including septum) remained. This heart tissue and the 2 blood samples were 
then further processed by the procedure explained in Chapter 4 to recover the fluorescent 
microspheres from the samples.  Briefly, the samples were digested in 2.3 M ethanolic 
KOH and 0.25 % Tween 80 for a period of 48 hours. At the end of digestion, 
microspheres were recovered by the sedimentation method and the fluorescent dye was 
extracted from them by using 3 ml of 2-ethoxy-ethyl-acetate. 
 
5.2 Measurement of Microsphere Number in Tissue and Blood Samples 
5.2.1 Measurement of fluorescence intensity 
On the last day of the sedimentation procedure, the samples were read for 
fluorescence intensity. Since microspheres of two different colors were used in the 
procedure, samples were read at two different (excitation / emission) wavelengths. By 
selecting filters in the spectrophotometer instrument, samples containing yellow-green 
microspheres were read at (485 nm / 530 nm) (excitation / emission) wavelengths, and 
samples containing red microspheres were read at (590 nm/ 645 nm) (excitation / 
emission) wavelengths. After setting the filters, the samples were placed in a 96 well 
plate reader and then scanned to measure fluorescence intensity (If).  The intensities 





5.2.2 Calculation of number of fluorescent microspheres from calibration curves 
The standard curves for fluorescent microspheres as obtained in Chapter 2 were 
expressed by the following linear relationships: 
For yellow-green microspheres:  If = 0.9256 (Ns) – 4.9102 
For red microspheres:   If = 1.0954 (Ns) + 0.8414 
where,  If = fluorescence intensity obtained from spectrophotometer 
                               Ns = number of fluorescent microspheres 
Using these equations for the standard curves and knowing the values of 
fluorescence intensity from the spectrophotometer, the number of fluorescent 
microspheres can be determined. 
To determine the number of yellow green microspheres in both blood and tissue samples:  
Ns = (If + 4.9102) / 0.9256  
To determine the number of red microspheres in both blood and tissue samples:  
Ns = (If – 0.8414) / 1.0954 
 
These inverse expressions of the standard curves were used to infer the number of 
microspheres in each sample (Ns) from the measured value of fluorescence intensity (If).  









Table 5.4 Number of fluorescent microspheres in blood and tissue samples in rat 1 
        Rat 1         Sample              If                 Ns 
Baseline : yellow- 
green microspheres 
        Tissue            16782           18136 
Baseline : yellow- 
green microspheres 
        Blood             2007             2174 
Adenosine : red 
microspheres 
       Tissue            50438            46045 
Adenosine : red 
microspheres 
       Blood           2748             2508 
 
Table 5.5 Number of fluorescent microspheres in blood and tissue samples in rat 2 
        Rat 2         Sample              If                 Ns 
Baseline : yellow- 
green microspheres 
        Tissue            18943           20471 
Baseline : yellow- 
green microspheres 
        Blood             2128             2304 
Adenosine : red 
microspheres 
       Tissue            56700            51761 
Adenosine : red 
microspheres 
       Blood           2969             2710 
 
5.3 Calculation of Coronary Blood Flow and Coronary Flow Reserve 
Coronary blood flow delivers oxygen rich blood to heart muscle.  The amount of blood 
flow increases in proportion to the amount of heart muscle.  For this reason, coronary 
blood flow is expressed as flow per gram of tissue (ml/min/g).  Microspheres serve as a 
tracer of blood flow, so that the relative amounts of blood flow in two tissue samples are 




Blood flow to heart Number of microspheres in heart sample
Reference blood flow Number of microspheres in blood sample
=  
 
Given that the reference blood flow was withdrawn at 0.5 ml/min, the following formula 




Blood flow to heart N  in heart sample 0.5 ml/min
Coronary Blood Flow
Mass of heart N  in blood sample mass of heart sample
= = •
 
where Ns is the measured number of microspheres.  The mass of the left ventricle sample 
was 0.734 g for rat 1 and 0.718 g for rat 2. 
Applying this formula to the data from each rat: 
For Rat 1: 
Baseline coronary flow:   (18136 / 2174) * (0.5 / 0.734) = 5.68 ml/min/g 
Adenosine coronary flow:  (46045 / 2508) * (0.5/ 0.734) = 12.5 ml/min/g 
For Rat 2:  
Baseline coronary flow:  (20471/2304) * (0.5 / 0.718) =   6.19 ml/min/g 
Adenosine coronary flow:  (51761/2710) * (0.5 / 0.718) =    13.3 ml/min/g 
Coronary flow reserve (CFR) is the ratio of the maximum blood flow through the 
coronary arteries (when they are maximally vasodilated) compared to the normal 
coronary blood flow when the animal is resting. Coronary flow reserve is used in 
diagnostics and treatment of patients suffering from conditions such as coronary artery 
disease. In the treatment of these conditions, vasodilators such as nitroglycerine are used 
to increase the rate of blood flow through the coronary arteries, and the measurement of 
CFR enables the efficacy of such interventions to be measured. When coronary flow 
reserve is used in medicine, it is usually expressed as a dimensionless number, which is 
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formed by dividing the maximal coronary blood flow by resting blood flow. This allows 
for an objective view, which can aid diagnosis and treatment. 
In the microsphere studies, coronary flow reserve was calculated as: 
Coronary flow reserve = (Coronary blood flow)adenosine / (Coronary blood flow)basal 
 For rat 1:  
Coronary flow reserve = (Coronary blood flow)adenosine / (Coronary blood flow)basal 
= 12.5 / 5.68 
= 2.20 
For rat 2:  
Coronary flow reserve = (Coronary blood flow)adenosine / (Coronary blood flow)basal 
= 13.3 / 6.19 
= 2.15 
5.4 Comparison with Coronary Flow Reserve 
Measured using Doppler Echocardiography 
Coronary flow reserve was also measured using Doppler echocardiography in a set of 6 
male Sprague-Dawley rats of the same age and range of body weights as the two rats 
used in the microsphere study.  These rats were also anesthetized using the same method 
as in the microsphere study.  Since the rats in both studies were of the same strain, age, 
gender,body mass, and anesthetic state, it was reasonable to assume that they should have 
similar coronary flow reserves. 
 However, there is one essential difference between the microsphere flow 
measurement and the ultrasound measurement:   Doppler echocardiography measures the 
velocity of blood movement (in mm/s), not the bulk flow of blood volume (in ml/s).  
However, if the cross-sectional area of the blood vessel being imaged does not change 
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significantly between the normal and vasodilated state, then the ratio of blood flow 
between vasodilated and normal states must be the same as the ratio of the velocity of 
blood movement.  Thus, if vessel area remains constant, the non-dimensional value for 
coronary flow reserve should be the same when measured by the ratio of velocities or by 
the ratio of bulk flows. 
 Since the vasodilator that we used (adenosine) primarily relaxes smooth muscle in 
the arterioles, it may not cause a significant relaxation of smooth muscle in the walls of 
the major, large coronary arteries.  If such relaxation did occur, then we would expect the 
coronary reserve measured by echo Doppler (velocity) to be less than the coronary 
reserve measured by microspheres (bulk flow), because vessel area ratio would be > 1: 
vasodilated vasodilated vasodilated
normal normal normal
Bulk Flow Vessel Area Velocity
Bulk Flow Vessel Area Velocity
= •  
Table 5.6 summarizes the results of the measurements of coronary flow reserve 
(CFR) by Doppler echocardiography.  These measurements were carried out by assistant 
professor Shumin Gao, MD/PhD, of the Department of Cell Biology and Molecular 
Medicine at UMDNJ-Newark.  The velocity of blood motion was measured in the left 
coronary artery of rats during the normal baseline state and after infusion of adenosine at 
the same rate (0.15 mg/min/kg) as used in the microsphere study. 
 As Table 5.6 shows, the average coronary flow reserve determined by Doppler 
echocardiography was 2.22 ± 0.14 (mean ± SEM).    This value was statistically 
indistinguishable from the measurement of coronary flow reserve found using fluorescent 
microspheres.  That is, the values for CFR from microspheres (2.15 and 2.2) both fell 
within the range of mean ± standard-error-of-the-mean from Doppler measurements.  
Additionally, the fact that the Doppler velocity ratio equaled or exceeded the bulk flow 
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measure was consistent with the assumption that large vessel area did not change 
significantly with adenosine, since that would have made the velocity ratio < bulk ratio. 
 
Table 5.6 Measurement of coronary flow reserve using Doppler echocardiography 












SDB-7 4w-sham  251.5 435.8 1.73 
SDB-8 4w-sham  405.1 805.4 1.99 
SDB-9 4w-sham  337.3 823.6 2.44 
SDB-10 4w-sham  318.5 859.3 2.70 
SD-CR-1 311.5 680.6 2.18 
SD-CR-2 450.4 1020.3 2.27 
mean 345.7 770.8 2.22 
SD 71.2 197.2 0.34 



















DISCUSSION AND FUTURE WORK 
 
The present study shows that fluorescent microspheres can be used to reliably determine 
coronary blood flow in rats under baseline conditions and after infusion with adenosine. 
There were no significant differences observed in coronary flow reserve measured with 
either Doppler echocardiography or fluorescent microspheres.  In addition, the absolute 
value of baseline coronary flow obtained in this study agreed well with the value 
published in a recent study on rats [22].  
               Fluorescent microspheres were used in this study. This technique has thus been 
demonstrated to be a reliable alternative to radioactive or colored microspheres for 
measuring organ blood flow in rats under normal conditions and under infusion with 
adenosine. In the present study, supernatants and pure microsphere samples were 
analyzed from each step of the tissue recovery protocol, which suggested that there was 
100% recovery of microspheres regardless of mass and blood flow capacity. The 
sedimentation method for the recovery of fluorescent microspheres was achieved by use 
of ethanolic solutions, which increased the specific gravity difference between 
microspheres and medium, aided by higher centrifugation speeds that avoided the loss of 
fluorescent microspheres.  
            The resolution of the fluorescence method is dependent on the amount of label per 
microsphere, the quantum efficiency of the fluorescent dye, and the sensitivity of the 
spectrophotometer. The latter is determined by light source intensity, transmittance of 
filters or monochromators used to select excitation and emission wavelengths, efficiency 
of photomultiplier tube, and the type of plate reader used. By using optimal excitation 
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and emission wavelengths, there was very good correlation between fluorescence 
intensity and number of microspheres across a wide range of concentrations.  
Although we had crimson fluorescent microspheres as an option along with the 
red and yellow-green microspheres that we used, we did not use crimson because of its 
low quantum efficiency and significant spillover into adjacent colors at higher 
concentrations.  
When two different colors of fluorescent microspheres were injected into the 
body of a rat under baseline conditions and under infusion of adenosine, there was a good 
relation between estimated blood flow across a wide range of tissue blood flow. 
Fluorescent microspheres produced no significant alteration in blood pressure during or 
after injection in rats. Use of red and yellow-green microspheres resulted in no spillover 
in the course of this study.    
                A dilution procedure was performed using known microsphere samples to 
obtain the calibration curve of fluorescence intensity versus microsphere number. Several 
trials of the dilution procedure were performed on each of the two microsphere colors. A 
linear regression equation was obtained for each graph plotted. These regressions were 
then averaged to obtain an standard curve for each fluorescent microsphere color that we 
used. Averaging increased the accuracy of the calibration thus resulting in a more reliable 
final value of coronary blood flow.  
  Because of the small blood volume in rats, we limited our investigation to two 
successive measurements by taking two reference blood samples each of 1 ml.  We 
calculated that – compared to the weight of the animal – this volume of reference blood 
withdrawn was less than 10% of the total blood volume in each rat, which should not 
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have affected the hemodynamics of the animal. In addition, after each reference blood 
withdrawal, saline was inflused into the rat which also helped to restore blood volume.  
Our study demonstrates that the fluorescent microsphere method is able to 
accurately reflect the increase in flow that occurs in rats after infusion of a coronary 
vasodilator, adenosine. Adenosine infusion produced nearly identical increases in 
myocardial blood flow (measured by fluorescnt microspheres) and in coronary blood 
velocity (measured by Doppler echocardiography).  The mean coronary blood flow 
reserve obtained by the fluorescent microsphere method was 2.18, which was within the 
standard estimate of the value for coronary flow velocity reserve obtained by the range-
gated Doppler echocardiography method.  
As reported in a recently published article [22], the value of mean myocardial 
blood flow in Sprague Dawley rats at baseline and after infusion with adenosine, were 5.9 
+/- 2.3 (ml/min/g) and 13.1+/-2.1(ml/min/g), respectively. In our study, using the same 
species of rat and the same coronary vasodilator, the values obtained at baseline and after 
infusion with adenosine were 5.94 and 12.9 (ml/min/g), respectively.  Thus, the values 
we observed in both conditions (baseline + vasodilated) fall within the 95% confidence 
interval of this recently reported data. This suggests that the procedures developed in this 
thesis for microsphere recovery (by the sedimentation method) and fluorescence 
measurement and calibration offer a reliable method for determining coronary blood flow 
in rats. 
               Colored microspheres are currently being used to determine coronary blood 
flow in rats in the laboratories of the Cellular Biology and Molecular Medicine 
Department at UMDNJ, Newark. We were thus able to collaborate with current expertise 
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in microsphere injection procedures, and this collaboration undoubtedly improved the 
reliability of our results compared to what we would have been able to achieve 
independently.  However, the samples of tissue and blood containing colored 
microspheres are currently sent out to a commercial processor to determine the number of 
microspheres and hence coronary blood flow.  The techniques applied in this thesis are 
thus new to this laboratory and offer a reasonable alternative to commercial processing to 
measure coronary blood flow.  
One drawback of our study is that only two animals were used for the procedure. 
This was due to the busy schedule of the collaborators at UMDNJ and the limited time 
window in which this thesis had to be completed.  However, the quality of agreement 
among the two studies that were performed – and their agreement with recent data 
reported in the literature – suggests that a larger study might have even more strongly 
supported the repeatability of the results.  
In the future, it would be important to see whether the fluorescent microsphere 
method could also be applied to measure coronary blood flow in mice.  We attempted 
two experiments on mice, but we experienced failure during the cardiac cannulation 
procedure. It appeared that the catheter used was too large in diameter and thus too stiff 
to be able to be guided into the left ventricle of mice. Use of a smaller diameter catheter 
might offer easier access to the left ventricle, however one would also have to evaluate 
whether microspheres could be injected at an adequate rate through such a smaller 
diameter.   Also, due to the very small blood volume of a mouse, it will be more difficult 
to obtain two reference blood samples without affecting the hemodynamics of the mouse.   
Finally, to achieve accurate measurements [38] sufficient numbers of microspheres will 
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have to be injected so that at least 400-500 spheres will be trapped in the left ventricular 
tissue (which typically has a mass of only 80-100 micrograms) and in each reference 
blood sample. 
Note that during the dilution procedure to obtain the calibration curves we used 
whole microspheres from the stock solution (with the fluorescent dye remaining within 
the microspheres). On the other hand, during the actual procedure after microspheres 
were recovered from the body of animal, the microspheres were dissolved chemically to 
release the dye into solution. We believe this is an adequate calibration procedure 
because only the ratio of fluorescent intensities matters in the determination of blood 
flow.  Because our calibrations showed that fluorescent intensity was linearly related to 
microsphere number throughout the range of interest, the ratio of intensities will be the 
same as the ratio of numbers.   Each microsphere dye might produce more intensity when 
free in solution because of limits to excitation and absorption of emitted light imposed 
when the dye remains inside a microsphere.   However, we assumed that this effect 
would apply equally to both the tissue and reference blood samples.  Thus, the ratio of 
fluorescent intensity would not be affected by whether the dye was in solution or 
remained within the microspheres.  
In conclusion, the fluorescent microsphere technique (a) is a reliable method for 
measuring coronary blood flows in rats;  (b) works well as a substitute for radioactive or 
colored microspheres, with advantages in safety and cost; and (c) provides repeatable 






DETAILS OF CALIBRATION PROCEDURE 
 
A dilution procedure was used to plot the calibration curve, each for yellow green 
microspheres and red microspheres, operating at different (Excitation/ Emission) 
wavelengths. 
 
The procedure is as follows: 
1) Vortex the bottle containing fluorescent microspheres using vortex mixer. Vortexing 
allows uniform mixing of the solution thus preventing aggregation and clumping of 
microspheres within the solution. 
 
2) Pull out 100µl or 200µl well agitated microspheres from the original microsphere 
containing bottle using 1ml plastic syringe. 
 
3) Transfer microspheres from syringe into a small cuvette carefully at the bottom of 
chamber. 
 
4) Vortex the cuvette to prevent sticking and clumping of microspheres within the 
solution and around the walls of cuvette. 
 
5) Immediately withdraw calibrated 50µl of sample using 200µl pipette. 
 
6) Add 450µl of (1X PBS + 2% Tween 80) solution to 50µl of microspheres. This makes 
a total of 500 µl @ 100 (spheres / µl) 
 
7) Take 100 µl of above solution and put it in a 96 well container. This is the test for 
10,000 microspheres. 
 
8) After 100 µl of solution is removed, 400 µl of solution remains. 
 
9) Perform 2:1 dilution on 400 µl solution by adding 400 µl of (1X PBS + 2% Tween 80) 
solution to the above 400 µl solution. 
 
10) This make a total of 800 µl solution. Take 100 µl of above solution and put it in a 96 
well container. This is the test for 5,000 microspheres. 
 
11) Out of 700 µl solution still remaining, take 500 µl of solution in a different cuvette. 
 
12) Add 500 µl of (1X PBS + 2% Tween 80) solution in above 500 µl solution. 
 
13) Vortex sample and immediately withdraw 100 µl solution and put it in a 96 well 
plate. This is the test for 2500 microspheres. 
 




15) Add 500 µl of (1X PBS + 2% Tween 80) solution in above 500 µl solution. 
 
16) Vortex sample and immediately withdraw 100 µl solution and put it in a 96 well 
plate. This is the test for 1250 microspheres. 
 
17) Out of 900 µl solution still remaining, withdraw 500 µl of solution in a different 
cuvette. 
 
18) Add 500 µl of (1X PBS + 2% Tween 80) solution in above 500 µl solution. 
 
19) Vortex sample and immediately withdraw 100 µl solution and put it in a 96 well 
plate. This is the test for 625 microspheres. 
 
20) Out of 900 µl solution still remaining, withdraw 500 µl of solution in a different 
cuvette 
 
21) Add 500 µl of (1X PBS + 2% Tween 80) solution in above 500 µl solution. 
 
22) Vortex sample and immediately withdraw 100 µl solution and put it in a 96 well 
plate. This is the test for 312 microspheres. 
 
23) The 96 well plate is then placed in a plate reader to determine the fluorescence 
intensity. 
 
Depending on the color of fluorescent microspheres, the (Excitation / Emission) 















CALIBRATION CURVES FOR FIVE TESTS PERFORMED ON EACH 
MICROSPHERE COLOR  
 
A dilution procedure as described in Chapter 2 was performed five times with each 
microsphere color to get an average calibration curve. With each trial, the readings were 
recorded on spectrophotometer and graphs were plotted on Microsoft Excel. The 
intercept equations for each trials were then averaged together to get a standard 
calibration curve. Yellow- green microspheres were used for getting a calibration curve 
which can be used for baseline calculations. Red microspheres were used for getting a 
calibration curve which can be used for vasodilation calculations. 
Trials done with yellow- green microspheres: 
Sample 1:  
Table 2.2  Representation of fluorescent intensities at various dilutions  
     Microsphere number      Fluorescence Intensity  
                        10000                        11363 
                          5000                         5964 
                          2500                        2808 
                          1250                           1407 
                           625                           717 






Figure 2.4  Excel plots showing the 1st  baseline calibration curve   
Sample 2:  
Table 2.3  Representation of fluorescent intensities at various dilutions   
     Microsphere number     Fluorescence Intensity        
                        10000                     9214 
                          5000                     4400 
                          2500                      2150 
                          1250                      1000 
                           625                        550 






Figure 2.5  Excel plots showing the 2nd baseline calibration curve   
Sample 3 :  
Table 2.4  Representation of fluorescent intensities at various dilutions 
     Microsphere number  Fluorescence Intensity 
                        10000                     8683 
                          5000                     4288 
                          2500                      2100 
                          1250                      1001 
                           625                        528 
                          312                       300 





Figure 2.6  Excel plots showing the 3rd  baseline calibration curve   
Sample 4: 
Table 2.5  Representation of various fluorescent intensities at various dilutions 
     Microsphere number    Fluorescence Intensity 
                        10000                     9110 
                          5000                     4792 
                          2500                      2000 
                          1250                      1068 
                           625                        629 







Figure 2.7  Excel plots showing the 4th  baseline calibration curve  
Sample 5:  
Table 2.6  Representation of various fluorescent intensities at various dilutions    
     Microsphere number     Fluorescence Intensity 
                        10000                     7752 
                          5000                     4245 
                          2500                      2039 
                          1250                      1200 
                           625                        501 
                          312                       284 










Figure 2.8  Excel plots showing the 5th  baseline calibration curve   
Trials done with red microspheres:  
Sample 1:  
Table 2.7   Representation of various fluorescent intensities at various dilutions. 
        Microsphere Number              Fluorescence Intensity 
                      10000                     11057       
                      5000                     5237 
                      2500                     2701 
                     1250                    1389 
                      625                        604 
                     312                    204 








Figure 2.9  Excel plots showing the 1st vasodilation calibration curve   
Sample 2:  
Table 2.8   Representation of various fluorescent intensities at various dilutions. 
        Microsphere Number                 Fluorescence Intensity 
                      10000                     8991  
                      5000                     4477 
                      2500                     1819 
                     1250                      867 
                      625                        507 
                      312                    394 











Figure 2.10  Excel plots showing the 2nd  vasodilation calibration curve   
Sample 3: 
 
Table 2.9   Representation of various fluorescent intensities at various dilutions 
        Microsphere Number              Fluorescence Intensity 
                      10000                     11573 
                      5000                     6171 
                      2500                     3000 
                     1250                      1682 
                      625                         800 
                      312                      500 















Table 2.10   Representation of various fluorescent intensities at various dilutions 
        Microsphere Number               Fluorescence Intensity 
                      10000                         11100 
                      5000                          6263 
                      2500                          3623 
                     1250                          1798 
                      625                             1000 
                      312                            450 










Figure 2.12  Excel plots showing the 4th vasodilation calibration curve   
Sample 5: 
 
Table 2.11   Representation of various fluorescent intensities at various dilutions 
        Microsphere Number                 Fluorescence Intensity  
                      10000                     12306  
                      5000                     6055 
                      2500                     2930 
                     1250                      1611 
                      625                         827 
                      312                      430 
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